WARF TECHNOLOGIES

UW-Madison researchers have developed methods for making and using modified influenza gene products, alone or in combination, to inhibit WT virus replication, to serve as immunostimulatory agents, or as attenuated vaccine backbones. This discovery allows for fine-tuning and optimization of the inhibitory activity of DIPs, producing a dual effect in which both the RNA itself and the novel protein it encodes coordinate to interfere with replication.

For More Information About the Inventors

• Andrew Mehle

Tech Fields

• Therapeutics & Vaccines : Vaccines